Chenlu Hou currently serves as the Director of R&D at Natera, a position held since November 2024. Prior to this role, Chenlu was with GRAIL from March 2016 to November 2024, where advancements in multi-cancer early detection tests were achieved through leadership in assay development and optimization as well as team management. Chenlu's scientific career includes significant contributions at Illumina, McKinsey & Company, and various research roles at the University of California, Berkeley, including a PhD in Electrical Engineering. Expertise spans across product development, assay optimization, strategic consulting, and innovative device design in the fields of bioengineering and electrical engineering.
This person is not in the org chart
This person is not in any teams
This person is not in any offices